✦ LIBER ✦

Effect of cyclical therapy with phosphorus and etidronate on axial bone mineral density in postmenopausal osteoporotic women

✍ Scribed by P. D. Miller; B. J. Neal; D. O. McIntyre; M. J. Yanover; M. S. Anger; L. Kowalski

Publisher: Springer-Verlag
Year: 1991
Tongue: English
Weight: 779 KB
Volume: 1
Category: Article
ISSN: 0937-941X
DOI: 10.1007/bf01625449

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The effect of low-dose cyclical etidrona

The effect of low-dose cyclical etidronate and calcium on bone mass in early postmenopausal women

✍ R. A. Evans; N. M. Somers; C. R. Dunstan; H. Royle; S. Kos 📂 Article 📅 1993 🏛 Springer-Verlag 🌐 English ⚖ 616 KB

Effects of cyclical etidronate therapy o

Effects of cyclical etidronate therapy on bone loss in early postmenopausal women who are not undergoing hormonal replacement therapy

✍ J. M. Pouilles; F. Tremollieres; C. Roux; J. L. Sebert; C. Alexandra; D. Goldber 📂 Article 📅 1997 🏛 Springer-Verlag 🌐 English ⚖ 758 KB

Effect of parathyroidectomy for primary

Effect of parathyroidectomy for primary hyperparathyroidism on bone mineral density in postmenopausal women

✍ Professor A. Sitges-Serra; L. García; R. Prieto; M. J. Peña; X. Nogués; J. J. Sa 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 127 KB 👁 2 views

Effects of bazedoxifene on bone mineral

Effects of bazedoxifene on bone mineral density, bone turnover, and safety in postmenopausal japanese women with osteoporosis

✍ Akira Itabashi; Kousei Yoh; Arkadi A Chines; Takami Miki; Masahiko Takada; Hiros 📂 Article 📅 2011 🏛 American Society for Bone and Mineral Research 🌐 English ⚖ 244 KB 👁 2 views

## Abstract This randomized, double‐blind, placebo‐controlled, dose‐response late phase 2 study evaluated the efficacy and safety of bazedoxifene in postmenopausal Japanese women 85 years of age or younger with osteoporosis. Eligible subjects received daily treatment with oral doses of bazedoxifene

The effect of rheumatoid arthritis and s

The effect of rheumatoid arthritis and steroid therapy on bone density in postmenopausal women

✍ Gerard M. Hall; Tim D. Spector; A. Jane Griffin; Ali S. M. Jawad; Margaret L. Ha 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 736 KB

Odanacatib in the treatment of postmenop

Odanacatib in the treatment of postmenopausal women with low bone mineral density: Three-year continued therapy and resolution of effect

✍ John A Eisman; Henry G Bone; David J Hosking; Michael R McClung; Ian R Reid; Ren 📂 Article 📅 2011 🏛 American Society for Bone and Mineral Research 🌐 English ⚖ 211 KB 👁 2 views

## Abstract The selective cathepsin K inhibitor odanacatib (ODN) progressively increased bone mineral density (BMD) and decreased bone‐resorption markers during 2 years of treatment in postmenopausal women with low BMD. A 1‐year extension study further assessed ODN efficacy and safety and the effec